21256 ⎘
Medicinal preparations containing active ingredients not provided for in groups - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
ORAL OCTREOTIDE FOR THE TREATMENT OF DISEASE
#6302METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING CANCER
#6303CYCLOSPORINE FORMULATIONS FOR USE IN THE PREVENTION OR TREATMENT OF PULMONARY CHRONIC GRAFT REJECTION
#6304Method of precision dosing
#6305Color Coded Cannabis Variety Pack and Directive of Use
#6306Application of Retinal Pigment Epithelial Cells as Corneal Endothelial Substitute
#6307APPLICATION OF NKG2D CAR-IMMUNOCYTE IN TREATMENT OF ANTI-AGING AND AGE-RELATED DISEASES
#6308METHODS AND COMPOSITIONS FOR USE OF THERAPEUTIC T CELLS IN COMBINATION WITH KINASE INHIBITORS
#6309INHIBITION OF NGLY1 FOR THE TREATMENT OF CANCER
#6310DRINK PRODUCT AND USE THEREOF
#6311Lipid Disulfide Prodrugs and Uses Related Thereto
#6312Intravenous Ganaxolone Formulations and Methods of Use in Treating Status Epilepticus and Other Seizure Disorders
#6313COMBINATION THERAPY
#6314METHOD OF TREATING HYPERTENSION
#6315USE OF PPAR-DELTA AGONISTS IN THE TREATMENT OF DISEASE
#6316COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#6317METHODS OF TREATING NEUROFIBROMATOSIS WITH PERILLYL ALCOHOL
#6318ANTI-INFLAMMATORY, ANTI-CANCER, AND ANTI-ANGIOGENIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF MAKING AND USING THEREOF
#6319Pharmaceutical Composition Comprising Mineralocorticoid Receptor Antagonist and Use Thereof
#6320CLOPIDOGREL FOR USE IN THE TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
#6321TREATMENT OF KRAS MUTANT CANCERS
#6322COMPOUNDS AND METHODS FOR TREATING VIRAL INFECTIONS
#6323HEXYLAMINE SALTS AND METHODS OF USING HEXYLAMINE
#6324Multivitamin
#6325PHARMACEUTICAL COMPOSITION CONTAINING TAXANE NANOAGGREGATES AND USE THEREOF
#6326Multiple unit dosage form having a therapeutic agent in combination with a nutritional supplement
#6327Oral Product Comprising an Antiviral Active Ingredient
#6328METHODS AND ASSAYS FOR SECRETOME ACTIVITY ANALYSIS
#6329COMPOSITIONS AND METHODS FOR PREDICTING RISK OF MODERATE TO SEVERE COVID-19 DISEASE
#6330PREVENTION OR TREATMENT OF WASTING SYNDROME
#6331PH20 polypeptide variants, formulations and uses thereof
#6332METHODS AND COMPOSITIONS FOR STIMULATING GAMMA DELTA T CELLS
#6333Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications
#6334MODIFIED INTERLEUKIN 2 (IL-2) POLYPEPTIDES, AND METHODS OF MAKING AND USING THE SAME
#6335METHOD OF TREATMENT OF IRRITABLE BOWEL SYNDROME
#6336DIHYDROIMIDAZO PYRIMIDO PYRIMIDINONE COMPOUND
#6337N-Linked Glycosylation Inhibitors and Methods of Using Same
#6338PYRIMIDINYL SULFONAMIDES AS INHIBITORS OF ACK1/TNK2 TYROSINE KINASE
#6339APPLYING THERAPEUTIC AGENTS FOR GENITAL AND ANAL PRE-CANCER TREATMENT, INCLUDING CERVICAL INTRAEPITHELIAL NEOPLASIA
#6340METHODS OF TREATING COLON CANCER USING NANOPARTICLE MTOR INHIBITOR COMBINATION THERAPY
#6341IMMUNOGENIC NANOVESICLES FOR CANCER IMMUNOTHERAPY
#6342METHODS FOR TREATING DIGITALLY-IDENTIFIED IL-4/IL-13 RELATED DISORDERS
#6343METHOD AND COMPOSITION FOR TREATING ARGINASE 1 DEFICIENCY
#6344METHODS OF TREATING INFERTILITY
#6345POLYPEPTIDES FOR USE IN THE TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES
#6346Use of NRG-1Beta1 for Detection and/or Treatment of Multiple Sclerosis
#6347METHODS, SYSTEMS, AND COMPOSITIONS FOR LEGUME-BASED PRODUCTION OF THERAPEUTIC PROTEINS AND THERAPEUTIC MEDICAL MATERIALS
#6348METHODS OF TREATING METASTATIC CANCERS USING AXL DECOY RECEPTORS
#6349COVERSIN FOR THE TREATMENT OF AUTOIMMUNE BLISTERING DISEASES
#6350ENGINEERED T CELL RECEPTORS TARGETING EGFR ANTIGENS AND METHODS OF USE
#6351ENGINEERED T CELL RECEPTORS TARGETING EGFR ANTIGENS AND METHODS OF USE
#6352PEGYLATED RAPAMYCIN COMPOUND AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#63536-THIO-2'-DEOXYGUANOSINE (6-THIO-DG) RESULTS IN TELOMERASE DEPENDENT TELOMERE DYSFUNCTION AND CELL DEATH IN VARIOUS MODELS OF THERAPY-RESISTANT CANCER CELLS
#6354COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND QUERCETIN FOR USE IN CARTILAGE DEGENERATION
#6355Method of Treating Viral Infection
#6356PHOSPHAPLATIN COMPOUNDS AS THERAPEUTIC AGENTS SELECTIVELY TARGETING HIGHLY GLYCOLYTIC TUMOR CELLS AND METHODS THEREOF
#6357PHARMACEUTICAL COMPOSITION FOR TREATMENT OF LUNG CANCER COMPRISING CANNABIDIOL AND ANTICANCER AGENT AS ACTIVE INGREDIENTS, AND USE THEREOF
#6358NOVEL USES
#6359COMBINATION CANCER THERAPY USING CHK INHIBITOR
#6360Methods of Treating Ischemic Disease by Administering an ATR Kinase Inhibitor
#6361Use of 5-HT3-Targeting Drugs for Treatment of Acute Kidney Injury
#6362INHIBITION OF GLYCOGEN SYNTHASE KINASE-3 (GSK-3)
#6363USE OF ZANAMIVIR IN PREPARATION OF DRUG FOR TREATING OR PREVENTING PREECLAMPSIA
#6364THERAPEUTIC MATERIAL WITH LOW pH AND LOW TOXICITY ACTIVE AGAINST AT LEAST ONE PATHOGEN FOR ADDRESSING PATIENTS WITH RESPIRATORY ILLNESSES
#6365METHODS AND COMPOSITIONS FOR TREATING CYTOKINE RELEASE SYNDROME
#6366METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING TISSUE CALCIFICATION
#6367CANNABINOIDS IN THE TREATMENT OF AUTISM SPECTRUM DISORDER
#6368PACKAGING FOR RAPIDLY INFUSING COMPOSITION
#6369Ophthalmic Suspension Base having a Micro-fluidized Positively Charged Nanoparticle
#6370ASSAYS FOR FABRY DISEASE TREATMENT
#6371GENETIC METHOD FOR DIAGNOSIS AND TREATMENT OF PRE AND POST CORONAVIRUS INFECTIONS
#6372PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
#6373PH20 polypeptide variants, formulations and uses thereof
#6374METHODS AND ANTIBODIES FOR MODULATION OF IMMUNORESPONSE
#6375ANTI-L1-CAM ANTIBODIES AND USES THEREOF
#6376METHODS AND TREATMENT INVOLVING EXCESS FREE LIGHT
#6377USE OF ANTI-PRO/LATENT MYOSTATIN ANTIBODY FOR TREATING SPINAL MUSCULAR ATROPHY
#6378Methods and composition for neutralization of influenza
#6379PEPTIDES AND USES THEREOF IN MODULATION OF AMYLOID-BETA PROTEIN DEGRADING PROTEASES
#6380AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER AND OTHER DISORDERS
#6381PRODRUG OF 5a-HYDROXY-6ß-[2-(1H-IMIDAZOL-4-YL)ETHYLAMINO]CHOLESTAN-3ß-OL AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME FOR USE IN THE TREATMENT OF CANCER
#6382IMIDAZOTHIAZOLE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF
#6383COMPOUNDS AND THEIR USE FOR TREATING NEUROPATHIC PAIN
#6384PYRIMIDINONE COMPOUNDS AND USES THEREOF
#63853,4-DIHYDRO-2,7-NAPHTHYRIDINE-1,6(2H,7H)-DIONES AS MEK INHIBITORS
#6386HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS
#6387BI-FUNCTIONAL COMPOUNDS AND METHODS FOR TARGETED UBIQUITINATION OF ANDROGEN RECEPTOR
#6388ANTIDIABETIC COMPOUNDS AND COMPOSITIONS
#6389Small molecules for treating cancer, inhibiting chemokine activity and/or inducing cell death
#6390Dephosphorylation-controlled extraction of phosphorylatable psychoactive alkaloids
#6391APPARATUS, METHOD, AND USE FOR ULTRASOUND MEDIATED MICROBUBBLE DELIVERY OF PHARMACEUTICAL COMPOSITIONS
#6392REVERSAL OF CELLULAR SENESCENCE BY TREATMENT WITH LOW FREQUENCY ULTRASOUND
#6393PREPARATION COMPRISING EXANATIDE FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT
#6394COMPLEX OF BETA-GLUCAN AND NUCLEIC ACID HAVING CONTROLLED PARTICLE SIZE
#6395METHODS AND KITS FOR IDENTIFYING SUBJECTS RESPONSIVE TO ARGININE DEPRIVATION THERAPY
#6396Nucleic Acid-Derivatized Therapeutics
#6397ADOPTIVE CELL THERAPY FOR TREATMENT OF CANCER ASSOCIATED WITH LOSS OF HETEROZYGOSITY
#6398METHODS FOR TREATING DIGITALLY-IDENTIFIED IL-4/IL-13 RELATED DISORDERS BY ADMINISTERING AN ANTI-IL4R-ALPHA ANTIBODY
#6399APPROACH FOR TREATMENT OF CANCER VIA IMMUNOMODULATION BY USING TALABOSTAT
#6400PEPTIDE VACCINES
#6401METHOD AND DRUG FOR INCREASING BDNF LEVEL
#6402Treatment Of Females Having BRCA1/2 Mutations With Human Chorionic Gonadotropin To Reduce The Risk Of Developing Breast Cancer
#6403Treatment of post-bariatric hypoglycemia with exendin (9-39)
#6404Medical use of interferon-lambda for the treatment of fibrosis
#6405Agents and Methods for Increasing Liver Immune Response
#6406METHOD FOR TREATING OR PREVENTING IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY (IPCV)
#6407GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF
#6408METHOD OF SENSITIZING CANCERS TO IMMUNOTHERAPY USING IMMUNOMODULATORY AGENTS
#6409COMPOSITIONS AND METHODS FOR BODY CONTOURING AND SURGICAL PROCEDURES
#6410A PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING LUNG INJURY, A PREPARATION METHOD THEREFOR AND A USE THEREOF
#6411HUMAN-DERIVED BACTERIA THAT INDUCE PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS
#6412COMPOSITIONS AND METHODS FOR TREATING HEMATOPOIETIC MALIGNANCY
#6413RAS MUTANT EPITOPE PEPTIDE AND T CELL RECEPTOR RECOGNIZING RAS MUTANT
#6414USE OF BETA-1,3-GLUCAN FOR MODULATING IMMUNE FUNCTION AND TREATING INTESTINAL INFLAMMATION
#6415COMPOSITIONS AND METHODS OF TREATING FANCONI ANEMIA
#6416Therapeutic treatment of breast cancer based on c-MAF status
#6417IMPROVED USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY
#6418IMPROVED USE OF CANNABINOIDS IN THE TREATMENT OF ALZHEIMER'S DISEASE
#6419Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols
#6420METHODS AND COMPOSITIONS RELATING TO CONTROLLING PSYCHEDELIC EFFECTS WITH SEROTONIN RECEPTOR MODULATORS
#6421MODULATORS OF THE INTEGRATED STRESS PATHWAY
#6422THERAPEUTIC COMPOSITIONS, COMBINATIONS, AND METHODS OF USE
#6423COMBINATION THERAPY
#6424USE OF FATTY ACID OXIDATION INHIBITORS AS ANTIMICROBIALS
#6425METHOD FOR THE TREATMENT OF DISEASES ASSOCIATED WITH SULFATASE DEFICIENCIES
#6426Roflumilast formulations with an improved pharmacokinetic profile
#6427Method of preventing and treating chemotherapy-induced alopecia
#6428COMPOSITION AND METHOD FOR TREATMENT OF DIABETES
#6429Non-linear dosing of mirdametinib
#6430ANTIHISTAMINE SEMI-SOLID CHEWABLE GEL COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF
#6431METHODS OF USING UMBILICAL CORD PRODUCTS FOR TREATMENT OF OCULAR SURFACE DISORDERS
#6432METHOD FOR MORSELIZING AND/OR TARGETING PHARMACEUTICALLY ACTIVE PRINCIPLES TO SYNOVIAL TISSUE
#6433METHODS AND COMPOSITIONS FOR DETECTING RISK OF CANCER RELAPSE
#6434CATALYTIC SEQUENCE BASED METHODS OF TREATING OR PREVENTING BACTERIAL INFECTIONS
#6435COMBINATION THERAPEUTICS USING TUMOR TREATING FIELDS (TTFIELDS)
#6436METHODS FOR TREATING CANCER WITH ANTI-GD2/GD3 ANTIBODIES
#6437MULTISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND CD38 AND 4-1BB, AND USES THEREOF
#6438Bispecific antibody binding BCMA and CD3
#6439METHODS OF TREATING SEVERE INSULIN RESISTANCE BY INTERFERING WITH GLUCAGON RECEPTOR SIGNALING
#6440METHODS FOR TREATING OR PREVENTING ACUTE RESPIRATORY DISTRESS SYNDROME
#6441Antibodies Directed Against T Cell Immunoglobulin and Mucin Protein 3 (TIM-3)
#6442ANTI-TIGIT ANTIBODIES AND METHODS OF USE
#6443ENGINEERED CD200R ANTIBODIES AND USES THEREOF
#6444C-TERMINAL SPARC FRAGMENTS FOR TREATING CANCER
#6445METHODS FOR TREATING A COMPLEMENT MEDIATED DISORDER CAUSED BY VIRUSES
#6446T cell receptors
#6447WAFER LEVEL CHIP SCALE PACKAGE WITH RHOMBUS SHAPE
#6448DECITABINE ANALOGS FOR IMMUNOLOGICAL AND ONCOLOGICAL THERAPY
#6449MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
#6450ETHANEDIAMINE-HETEROCYCLE DERIVATIVES AS INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASES
#6451DRUG-LIKE MOLECULES AND METHODS FOR THE THERAPEUTIC TARGETING OF MICRORNA-21
#6452DOUBLE DEGRADERS AND USES THEREOF
#6453Broad Spectrum Antiviral Compositions and Methods
#6454PLASMA KALLIKREIN INHIBITORS
#6455COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING DISEASES
#6456Quaternary tryptamines and their therapeutic uses
#6457Treatment of cataplexy
#6458PSMA INHIBITOR, COMPOUND AND APPLICATION
#6459PERFUSION-GUIDED GENE THERAPY FOR IMPROVING CANCER TREATMENT
#6460ANTI-CLDN18.2 ANTIBODY, DRUG CONJUGATE, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#6461ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE
#6462PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA)-TARGETED PRODRUG FOR SELECTIVE KILLING OF CELLS EXPRESSING PSMA
#6463NEOANTIGENS AND METHODS OF THEIR USE
#6464METHODS OF USING PLATELET FACTOR 4 AS AN ANTIMICROBIAL AGENT
#6465MODIFIED FIBROBLAST GROWTH FACTOR 21 (FGF-21) FOR USE IN METHODS FOR TREATING NONALCOHOLIC STEATOHEPATITIS (NASH)
#6466COMPOSITIONS, METHODS AND KITS FOR TREATING COMPLEMENT RELATED DISORDERS
#6467Compositions Containing a Pharmacophore with Selectivity to Diseased Tissue and Methods of Making Same
#6468PD-1 Peptide Inhibitors
#6469TG2 INHIBITORS FOR IMPROVING MUCOCILIARY CLEARANCE IN RESPIRATORY DISEASES
#6470Dual acting polymers in an osmotic film for topical application to treat inflammatory diseases and cytokine release syndrome
#6471ETHANOLIC EXTRACT OF SEEDS OF SOLANUM MELONGENA, METHOD FOR OBTAINING IT, PHARMACEUTICAL COMPOSITION CONTAINING IT AND USE THEREOF AS AN ANTITUMOUR AGENT
#6472COMBINED FUNGAL COMPOSITION FOR MODULATING AN INFLAMMATORY RESPONSE
#6473Allograft tolerance without the need for systemic immune suppression
#6474GENETIC MODIFICATIONS FOR XENOTRANSPLANTATION
#6475PD-1 DECOY VARIANTS FOR IMMUNOTHERAPY
#6476COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING VENOM RELATED POISONING
#6477TOPICAL CHLORINE DIOXIDE TREATMENT FOR MAMMALIAN TEATS
#6478USE OF GABAA MODULATORS FOR TREATMENT OF RESPIRATORY CONDITIONS
#6479Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors
#6480METHODS OF TREATING NEUROLOGICAL VENTILATORY INSUFFICIENCY
#6481Methods of treating disorders using CSF1R inhibitors
#6482REFINED USES OF GABA A RECEPTOR MODULATORS IN TREATMENT OF FRAGILE X SYNDROME
#6483USE OF ATR AND CHK1 INHIBITOR COMPOUNDS
#6484COMPOSITION, USES, AND METHODS OF TREATING SPINAL DISC DEGENERATION THROUGH SONIC HEDGEHOG SIGNALING PATHWAY
#6485THERAPEUTIC SMALL MOLECULES FOR TREATMENT OF PULMONARY HYPERTENSION
#6486Inhibition of crystal growth of roflumilast
#6487PHARMACEUTICALS FOR COVID19 TREATMENT
#6488LONG-ACTING SPIRO-ISOXAZOLINE ANTIPARASITIC COMPOSITIONS
#6489SYNERGISTIC OPHTHALMOLOGICAL COMPOSITION IN A LOW-CONCENTRATION DOSE THAT IS EFFECTIVE IN THE PREVENTION, CONTROL AND ERADICATION OF PRESBYOPIA
#6490COMPOSITIONS AND METHODS FOR TREATING HEMATOLOGICAL MALIGNANCIES
#6491PLECTRANTHUS AMBOINICUS EXTRACT FOR USE IN ALLEVIATION OF RADIATION-INDUCED SKIN DISORDERS
#6492NEW THERAPY CONCEPT FOR THE TREATMENT OF CORONA INFECTIONS, ESPECIALLY COVID-19 INFECTIONS
#6493USE OF DIHYDROMYRICETIN AS EPIGENETIC ACTIVE INGREDIENT FOR COSMETIC OR DERMATOLOGICAL SKIN CARE
#6494Combined Therapy Against Cancer
#6495HICA FOR USE IN PROPHYLAXIS AND/OR TREATMENT OF A DISEASE OR CONDITION INVOLVING DEGRADATION OF CARTILAGE AND/OR DISRUPTION OF CARTILAGE HOMEOSTASIS AND/OR INTEGRITY
#6496Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent and statin
#6497System and Method for Controlling the Humidity and Pressure in a Luminaire
#6498FIBRIN PARTICLES AND METHODS OF MAKING THE SAME
#6499SUSTAINED-RELEASE FORMULATIONS OF COLCHICINE AND METHODS OF USING SAME
#6500ACETIC ACID AS PROCESSING AID IN SPRAY DRYING FOR BASIC DRUGS
#6501EMULSIONS FOR TREATING MUCOUS MEMBRANE INFECTIONS
#6502Method for Preparing an Aqueous Nanocrystalline Suspension Containing Nanocrystals of Pharmaceutically Active Ingredient and a Combination of Stabilizers, Aqueous Nanocrystalline Suspension and Methods of Use Thereof
#6503PUNCTAL PLUGS CONTAINING MICELLE-ENCAPSULATED OPHTHALMIC PHARMACEUTICALS AND METHODS FOR MAKING THEREOF
#6504COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA
#6505Vasoconstriction compositions and methods of use
#6506KITS, SYSTEMS, AND METHODS FOR REDUCING SURGICAL SITE INFECTIONS
#6507METHODS FOR IDENTIFYING DRIVERS OF IMMUNE RESPONSES USING MOLECULAR EXPRESSION SIGNATURES OF IMMUNOMODULATING AGENTS
#6508COMBINATORIAL IMMUNOTHERAPEUTIC METHODS AND COMPOSITIONS FOR PANCREATIC DUCTAL ADENOCARCINOMA TREATMENT
#6509LIGHT INHIBITORS FOR SCLERODERMA AND SKIN FIBROTIC DISEASE TREATMENT
#6510ANTIBODIES AND METHODS OF USE THEREOF
#6511IL-23R antagonists to reprogram intratumoral T regulatory cells into effector cells
#6512Anti-AXL Antagonistic Antibodies
#6513ANTI-cMET ANTIBODY
#6514METHODS OF TREATING NEUROMYELITIS OPTICA SPECTRUM DISORDER
#6515METHOD OF TREATMENT OF A TUMOR WITH IL-8 ANTIBODY
#6516HUMANISED ANTIBODIES AGAINST PATHOGENIC FUNGI
#6517COMPOSITIONS AND METHODS FOR PREVENTING, INHIBITING, DISRUPTING, OR TREATING A POLYMICROBIAL BIOFILM
#6518Neutralizing Antibodies that Bind the SARS-COV-2 S Protein
#6519HETEROCYCLIC SPIRO COMPOUNDS AND METHODS OF USE
#6520Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
#6521TRYPTAMINE DERIVATIVES AND THEIR THERAPEUTIC USES
#65224-pivaloyloxy-n-methyltryptammonium chloride
#6523P62-ZZ CHEMICAL INHIBITOR
#6524Drug Delivery Devices with Drug-Permeable Component and Methods
#6525ANTIMICROBIAL CATHETERS
#6526METHODS FOR TREATING AND DIAGNOSING BLINDING EYE DISEASES
#6527PROINFLAMMATORY PRODRUGS
#6528FORMULATIONS AND USES THEREOF
#6529TREATMENT OF RECURRENT GIOBLASTOMA WITH PERILLYL ALCOHOL
#6530ENGINEERED IPSC AND IMMUNE EFFECTOR CELLS FOR HETEROGENOUS TUMOR CONTROL
#6531STAT-ACTIVATED MACROPHAGES, COMPOSITIONS, AND USES THEREOF
#6532NEOANTIGENS AND METHODS OF THEIR USE
#6533Method and compositions for inhibiting or preventing adverse effects of oral antibiotics
#6534TYPE E BOTULINUM TOXIN TO TREAT BOTULISM
#6535ANTIVIRAL AGENTS
#6536Lisinopril formulations
#6537USE OF PROBIOTIC COMPONENT AND PHARMACEUTICAL COMPOSITION CONTAINING PROBIOTIC COMPONENT
#6538AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF HEADACHES
#6539A MYCOBACTERIUM FOR USE IN CANCER THERAPY
#6540EXTRACELLULAR VESICLES FROM PREVOTELLA
#6541COMPOSITION FOR TREATING INFECTIOUS DISEASES, COMPRISING EXOSOMES DERIVED FROM THROMBIN-TREATED STEM CELLS
#6542TOPICAL COMPOSITIONS INCORPORATING SILICA FIBERS
#6543Bortezomib compositions
#6544INHIBITION OF HIV INFECTION THROUGH CHEMOPROPHYLAXIS
#6545A Method of Treating Depression by Immune Modulation
#6546CANNABINOID-CONTAINING COMPOSITIONS AND USE FOR TREATING AND PREVENTING DISEASES
#6547ADJUVANT THERAPY FOR USE IN PROSTATE CANCER TREATMENT
#6548FLUMAZENIL FORMULATIONS FOR SUBCUTANEOUS INJECTION AND METHODS OF TREATMENT USING GABA RECEPTOR MODULATORS
#6549Methods of treating B-cell proliferative disorder
#6550COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#6551COMBINATION THERAPY WITH AN ANTITUMOR ALKALOID
#6552METHODS OF TREATING TUMORS AND CANCERS HAVING DYSREGULATED WNT SIGNALING PATHWAYS
#6553ALPHA-2 ADRENERGIC RECEPTOR AGONISTS TO REDUCE MORTALITY AND IMPROVE OUTCOMES IN VIRAL RESPIRATORY SYNDROMES
#6554MODULATORS OF GTPASES AND THEIR USE
#6555Transmucosal dephosphorylated psychoactive alkaloid composition and preparation thereof
#6556METHODS TO SENSITIZE CANCER CELLS TO IMMUNE ATTACK USING ATRACTYLENOLIDE I
#6557Disorders implicating PUFA oxidation
#6558METHOD OF TREATING OR PREVENTING NEURODEGENERATION
#6559Use of cannabidiol in treatment of pulmonary hypertension
#6560RUXOLITINIB OR DEUTERATED RUXOLITINIB COMPOSITION AND USES THEREOF
#6561COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA
#6562ANTIBODIES AND METHODS OF USE THEREOF
#6563SUSTAINED ANTIBODY AND IMMUNOTHERAPEUTIC DELIVERY TO CERVICAL LYMPH NODES
#6564Polyomavirus neutralizing antibodies
#6565SUBSTITUTED PYRIMIDINES AND METHODS OF USE
#65662,6-DISUBSTITUTED PYRIDINE DERIVATIVE
#6567Anesthetic compounds and methods of making and using same to treat or prevent pain symptoms
#6568Anesthetic compounds and methods of making and using same to treat or prevent pain symptoms
#6569Anesthetic compounds and methods of making and using same to treat or prevent pain symptoms
#6570METHODS FOR TREATING HORMONAL DISORDERS
#6571RADIOLABELED ETHER DENDRIMER CONJUGATES FOR PET IMAGING AND RADIOTHERAPY
#6572Optimized mini-dystrophin genes and expression cassettes and their use
#6573SIRNA-NANOBOWL-MEDIATED INTERVENTION OF COVID-19
#6574SARS-CoV-2 VACCINES AND USES THEREOF
#6575MODIFIED CHIKUNGUNYA VIRUSES AND SINDBIS VIRUSES AND USES THEREOF
#6576Collagen daily with enzyme inhibitors for anti-aging
#6577AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE INTRANASAL SYSTEM
#6578A METHOD FOR EFFICIENT MICROGLIA REPLACEMENT
#6579SPECIFIC TARGETING OF TUMOR-INFILTRATING REGULATORY T CELLS (TREGS) USING ICOS AND IL-1R
#6580THERAPEUTIC CARBON MONOXIDE FORMULATIONS
#6581Methods and compositions for treating carbapenem-resistant klebsiella pneumoniae infections
#6582Compositions and methods for treating diseases associated with drug washout due to fluid secretion
#6583METHODS AND COMPOSITIONS FOR DIFFERENTIATING STEM CELLS
#6584METHODS TO TREAT INFLAMMATORY BOWEL DISEASE
#6585Methods of treating B-cell proliferative disorder
#6586COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#6587Co-agents as Therapy Against Anaerobic Pathogens
#6588ANTI-METHANOGENIC LOVASTATIN ANALOGS OR DERIVATIVES AND USES THEREOF
#6589Method of treating cancer using selective estrogen receptor modulators
#6590SILICASOME NANOCARRIER FOR METAL-BASED DRUG DELIVERY
#6591COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA
#6592Barrier system
#6593Systems and Methods for Assessing Mutational Burden of Neoplasms And Associated Treatments Thereof
#6594METHODS AND COMPOSITIONS FOR CANCER IMMUNOTHERAPY
#6595COMPOSITION FOR TREATING RETINAL OR CHOROIDAL DISEASES, CONTAINING ACTA2 INHIBITOR AS ACTIVE INGREDIENT
#6596DIAGNOSTIC AND THERAPEUTIC METHODS FOR CANCER
#6597MONOAMINE OXIDASE BLOCKADE THERAPY FOR TREATING CANCER THROUGH REGULATING TUMOR ASSOCIATED MACROPHAGES (TAMS)
#6598COMPOSITIONS FOR AND METHODS OF TREATING CANCER
#6599Methods for treating an ocular condition with cellular fibronectin compositions
#6600METHODS OF TREATING, AMELIORATING, AND/OR PREVENTING COVID-19 INFECTION AND RELATED INFLAMMATION